Gilead Sciences, Inc.
INTEGRASE INHIBITORS FOR THE PREVENTION OF HIV

Last updated:

Abstract:

The present invention provides methods of preventing HIV in a subject, comprising administering to the subject a therapeutically effective amount of bictegravir, or a pharmaceutically acceptable salt thereof, optionally in combination with one or more additional therapeutic agents. Methods of reducing the risk of acquiring HIV (e.g., HIV-1 and/or HIV-2) are also provided.

Status:
Application
Type:

Utility

Filling date:

18 Sep 2019

Issue date:

23 Dec 2021